These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 17318198

  • 21. CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice.
    Mizuguchi H, Koizumi N, Hosono T, Ishii-Watabe A, Uchida E, Utoguchi N, Watanabe Y, Hayakawa T.
    Gene Ther; 2002 Jun; 9(12):769-76. PubMed ID: 12040458
    [Abstract] [Full Text] [Related]

  • 22. Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon.
    Kurachi S, Koizumi N, Sakurai F, Kawabata K, Sakurai H, Nakagawa S, Hayakawa T, Mizuguchi H.
    Gene Ther; 2007 Feb; 14(3):266-74. PubMed ID: 17006548
    [Abstract] [Full Text] [Related]

  • 23. Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses.
    Hoffmann D, Meyer B, Wildner O.
    J Gene Med; 2007 Sep; 9(9):764-78. PubMed ID: 17640083
    [Abstract] [Full Text] [Related]

  • 24. Biophysical targeting of adenovirus vectors for gene therapy.
    Silman NJ, Fooks AR.
    Curr Opin Mol Ther; 2000 Oct; 2(5):524-31. PubMed ID: 11249755
    [Abstract] [Full Text] [Related]

  • 25. Dual targeting of gene delivery by genetic modification of adenovirus serotype 5 fibers and cell-selective transcriptional control.
    Work LM, Ritchie N, Nicklin SA, Reynolds PN, Baker AH.
    Gene Ther; 2004 Aug; 11(16):1296-300. PubMed ID: 15292916
    [Abstract] [Full Text] [Related]

  • 26. Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection.
    Lamfers M, Idema S, van Milligen F, Schouten T, van der Valk P, Vandertop P, Dirven C, Noske D.
    Cancer Lett; 2009 Feb 08; 274(1):78-87. PubMed ID: 18842332
    [Abstract] [Full Text] [Related]

  • 27. Novel adenoviral gene delivery system targeted against head and neck cancer.
    Li D, Guang W, Abuzeid WM, Roy S, Gao GP, Sauk JJ, O'Malley BW.
    Laryngoscope; 2008 Apr 08; 118(4):650-8. PubMed ID: 18176343
    [Abstract] [Full Text] [Related]

  • 28. Oncolytic adenoviral vector carrying the cytosine deaminase gene for melanoma gene therapy.
    Liu Y, Deisseroth A.
    Cancer Gene Ther; 2006 Sep 08; 13(9):845-55. PubMed ID: 16710344
    [Abstract] [Full Text] [Related]

  • 29. A histone deacetylase inhibitor enhances adenoviral infection of renal cancer cells.
    Okegawa T, Sayne JR, Nutahara K, Pong RC, Saboorian H, Kabbani W, Higashihara E, Hsieh JT.
    J Urol; 2007 Mar 08; 177(3):1148-56. PubMed ID: 17296436
    [Abstract] [Full Text] [Related]

  • 30. Comparison of viral vectors: gene transfer efficiency and tissue specificity in a bladder cancer model.
    Siemens DR, Crist S, Austin JC, Tartaglia J, Ratliff T.
    J Urol; 2003 Sep 08; 170(3):979-84. PubMed ID: 12913754
    [Abstract] [Full Text] [Related]

  • 31. Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma.
    Liu Y, Ye T, Sun D, Maynard J, Deisseroth A.
    Hum Gene Ther; 2004 Jul 08; 15(7):637-47. PubMed ID: 15242524
    [Abstract] [Full Text] [Related]

  • 32. A simplified cloning strategy for the generation of an endothelial cell selective recombinant adenovirus vector.
    Mahanivong C, Krüger JA, Bian D, Reisfeld RA, Huang S.
    J Virol Methods; 2006 Jul 08; 135(1):127-35. PubMed ID: 16581140
    [Abstract] [Full Text] [Related]

  • 33. Adenovirus 5 vector genetically re-targeted by an Affibody molecule with specificity for tumor antigen HER2/neu.
    Magnusson MK, Henning P, Myhre S, Wikman M, Uil TG, Friedman M, Andersson KM, Hong SS, Hoeben RC, Habib NA, Ståhl S, Boulanger P, Lindholm L.
    Cancer Gene Ther; 2007 May 08; 14(5):468-79. PubMed ID: 17273181
    [Abstract] [Full Text] [Related]

  • 34. Polyamine depletion by ODC-AdoMetDC antisense adenovirus impairs human colorectal cancer growth and invasion in vitro and in vivo.
    Zhang B, Liu XX, Zhang Y, Jiang CY, Hu HY, Gong L, Liu M, Teng QS.
    J Gene Med; 2006 Aug 08; 8(8):980-9. PubMed ID: 16783835
    [Abstract] [Full Text] [Related]

  • 35. Oncolytic adenoviral therapy in gallbladder carcinoma.
    Tekant Y, Davydova J, Ramirez PJ, Curiel DT, Vickers SM, Yamamoto M.
    Surgery; 2005 May 08; 137(5):527-35. PubMed ID: 15855925
    [Abstract] [Full Text] [Related]

  • 36. Peptide targeting of adenoviral vectors to augment tumor gene transfer.
    Ballard EN, Trinh VT, Hogg RT, Gerard RD.
    Cancer Gene Ther; 2012 Jul 08; 19(7):476-88. PubMed ID: 22595794
    [Abstract] [Full Text] [Related]

  • 37. Fiber-modified adenoviruses for targeted gene therapy.
    Wu H, Curiel DT.
    Methods Mol Biol; 2008 Jul 08; 434():113-32. PubMed ID: 18470642
    [Abstract] [Full Text] [Related]

  • 38. Retargeting of adenoviral vectors to neurons using the Hc fragment of tetanus toxin.
    Schneider H, Groves M, Mühle C, Reynolds PN, Knight A, Themis M, Carvajal J, Scaravilli F, Curiel DT, Fairweather NF, Coutelle C.
    Gene Ther; 2000 Sep 08; 7(18):1584-92. PubMed ID: 11021597
    [Abstract] [Full Text] [Related]

  • 39. Coxsackie and adenovirus receptor binding ablation reduces adenovirus liver tropism and toxicity.
    Yun CO, Yoon AR, Yoo JY, Kim H, Kim M, Ha T, Kim GE, Kim H, Kim JH.
    Hum Gene Ther; 2005 Feb 08; 16(2):248-61. PubMed ID: 15761264
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.